Evidence map›Paper›PMID 31219218›Full record

ArticleXenotransplantation2019

The role of human CD46 in early xenoislet engraftment in a dual transplant model.

Kannan P Samy, Qimeng Gao, Robert Patrick Davis, Mingqing Song, Zachary W Fitch, Michael S Mulvihill, Andrea L MacDonald, Frank V Leopardi, Tam How, Kyha D Williams and 4 more

Open access · greenAbstract read
In one paragraph

Article in Xenotransplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Complement and T cell activation in transplantation.Transplantation reviews (Orlando, Fla.) · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Clinically available immunosuppression averts rejection but not systemic inflammation after porcine islet xenotransplant in cynomolgus macaques.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Kannan P SamyDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina.
Qimeng GaoDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina.ORCID 0000-0002-2456-7672
Robert Patrick DavisDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina.
Mingqing SongDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina.
Zachary W FitchDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina.
Michael S MulvihillDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina.
Andrea L MacDonaldDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina.
Frank V LeopardiDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina.
Tam HowDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina.
Kyha D WilliamsDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina.
Gayathri R DeviDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina.
Bradley H CollinsDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina.
Xunrong LuoDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina.
Allan D KirkDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina.
Duke University · US

Funding

Neonatal Porcine Islet Xenografts for the Treatment of Type 1 DiabetesU01AI090956 · NIAID · EMORY UNIVERSITY · PI KIRK, ALLAN D., LUO, XUNRONG · 2010 to 2024
$14.8M
Stimulating Access to Research in Residency (StARR) - NIAIDR38AI140297 · NIAID · DUKE UNIVERSITY · PI Rachel G Greenberg, David H. Harpole · 2018 to 2026
$2.4M
National Institute of Health AI090956NIAID NIH HHS R38 AI140297NIAID NIH HHS U01 AI090956
6 · The paper itself

Abstract

backgroundMembrane cofactor protein CD46 attenuates the complement cascade by facilitating cleavage of C3b and C4b. In solid organ xenotransplantation, organs expressing CD46 have been shown to resist hyperacute rejection. However, the incremental value of human CD46 expression for islet xenotransplantation remains poorly defined.

methodsThis study attempted to delineate the role of CD46 in early neonatal porcine islet engraftment by comparing Gal-knocked out (GKO) and hCD46-transgenic (GKO/CD46) islets in a dual transplant model. Seven rhesus macaques underwent dual transplant and were sacrificed at 1 hour (n = 4) or 24 hours (n = 3). Both hemilivers were recovered and fixed for immunohistochemistry (CD46, insulin, neutrophil elastase, platelet, IgM, IgG, C3d, C4d, CD68, Caspase 3). Quantitative immunohistochemical analysis was performed using the Aperio Imagescope.

resultsWithin 1 hour of intraportal infusion of xenografts, no differences were observed between the two types of islets in terms of platelet, antibody, or complement deposition. Cellular infiltration and islet apoptotic activity were also similar at 1 hour. At 24 hours, GKO/CD46 islets demonstrated significantly less platelet deposition (P = 0.01) and neutrophil infiltration (P = 0.01) compared to GKO islets. In contrast, C3d (P = 0.38) and C4d (P = 0.45) deposition was equal between the two genotypes.

conclusionsOur findings suggest that expression of hCD46 on NPIs potentially provides a measurable incremental survival advantage in vivo by reducing early thrombo-inflammatory events associated with instant blood-mediated inflammatory reaction (IBMIR) following intraportal islet infusion.

Indexed as

Transplantation, HeterologousAnimalsAnimals, Genetically ModifiedAntibodiesComplement ActivationGraft RejectionHumansInflammationIslets of LangerhansIslets of Langerhans TransplantationMacaca mulattaMembrane Cofactor ProteinTransplantsAntibodiesCD46 protein, humanMembrane Cofactor ProteinCD46instant blood-mediated inflammatory reactionislet transplantationxenotransplantation

Identifiers

PMID31219218
PMCPMC6908747
OpenAlexW2950501366

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.